尊龙凯时人生就是搏·(中国区)官方网站
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Information Disclosure
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2023.09.21
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
2023.09.04
INTERIM DIVIDEND FOR 2023
2023.08.29
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE, 2023
2023.08.25
INTERIM DIVIDEND FOR 2023
2023.08.25
VOLUNTARY ANNOUNCEMENT - ENTERING INTO EXCLUSIVE LICENSE AND COOPERATION AGREEMENT WITH INVENTISBIO
2023.08.03
NOTIFICATION OF BOARD MEETING
2023.08.01
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023
2023.08.01
首页
上一页
21
22
23
24
25
26
...
53
尾页
下一页